CRNX vs UPST · rev $35.9M vs P/E 74, rev $672.9M
Crinetics Pharmaceuticals Inc (CRNX) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
CRNX currently screens at market cap $2.76B. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the CRNX and UPST stock pages for the full models.
Not investment advice.